Should I order a PT (prothrombin time) or SGPT (ALT) to evaluate liver function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SGPT (ALT) is the Appropriate Test for Evaluating Liver Function

For evaluating liver function, you should order SGPT (ALT), not PT (prothrombin time). These tests serve fundamentally different purposes in hepatic assessment.

Understanding the Distinction

SGPT/ALT: Marker of Hepatocellular Injury

  • ALT is the primary marker for detecting hepatocellular damage and is highly specific for liver injury, as it is concentrated predominantly in hepatocytes 1, 2
  • ALT elevations indicate active liver cell injury and are used to screen for and identify acute and chronic liver disease 3, 4
  • Normal ALT ranges are 29-33 IU/L for males and 19-25 IU/L for females; levels above this warrant assessment 1, 4
  • Elevated ALT has been associated with increased liver-related mortality, making it a critical screening tool 4

PT/INR: Marker of Hepatic Synthetic Function

  • PT measures clotting factor production (factors II, V, VII, IX, X) and reflects synthetic function, not hepatocellular injury 1
  • PT only becomes prolonged when there is loss of >70% of synthetic function, indicating severe or advanced liver disease 1
  • PT can be elevated due to vitamin K deficiency (from fat malabsorption or cholestasis) independent of liver disease 1
  • The INR was specifically designed and validated only for monitoring warfarin therapy, not as a general liver function test 5, 6

Clinical Algorithm for Liver Assessment

Initial screening should include:

  • ALT and AST (hepatocellular injury markers)
  • Alkaline phosphatase (cholestatic injury marker)
  • Bilirubin (hepatic metabolism)
  • Albumin and PT/INR (synthetic function - reserved for assessing severity in known liver disease) 1, 2

When to Order Each Test

Order ALT when:

  • Screening for liver disease in asymptomatic or symptomatic patients
  • Evaluating metabolic risk factors, medication effects, or alcohol use
  • Monitoring known liver conditions
  • The BALLETS study demonstrated that ALT and alkaline phosphatase identify the vast majority of adults with liver disease 1

Order PT/INR when:

  • Assessing severity of established liver disease
  • Evaluating for acute liver failure (PT <50% defines severe acute liver failure) 7
  • Monitoring patients with decompensated cirrhosis
  • Not for routine screening or predicting procedural bleeding risk in stable cirrhosis 8

Critical Pitfalls to Avoid

  1. Do not use PT/INR as a screening test for liver disease - it only becomes abnormal with advanced hepatic dysfunction 1

  2. Do not repeat PT/INR before routine procedures in stable cirrhotic patients - guidelines recommend against extensive preprocedural testing including repeated PT/INR measurements 8

  3. Do not interpret INR in liver disease patients the same as warfarin patients - the standard INR scale is only validated for VKA monitoring, not liver disease assessment 5, 6

  4. Baseline liver function testing should include ALT/SGPT for patients at risk for liver disease, including those with HIV, pregnant/postpartum women, chronic liver disease history, or regular alcohol use 9

The evidence consistently demonstrates that ALT (SGPT) is the appropriate initial test for evaluating liver function and detecting hepatocellular injury, while PT is reserved for assessing synthetic function in patients with known, advanced liver disease 1, 2, 3, 4.

Related Questions

In a patient with elevated alkaline phosphatase and gamma‑glutamyl transferase and a normal liver ultrasound, what are the next steps in evaluation?
What is the interpretation of the liver function test results showing total bilirubin 0.9 mg/dL, direct bilirubin 0.3 mg/dL, AST 61 U/L, ALT 142 U/L, alkaline phosphatase 178 U/L, albumin 3.6 g/dL, and globulin 3.1 g/dL?
What is the recommended evaluation for a patient with a normal complete blood count and mildly elevated alanine aminotransferase (ALT)?
Can you interpret these liver function test results: AST 80 U/L (high), ALT 56 U/L (high), alkaline phosphatase 1,476 U/L (high), total protein 5.7 g/dL (low), albumin 2.4 g/dL (low), total bilirubin 2.0 mg/dL (high), direct bilirubin 1.7 mg/dL (high)?
What is the appropriate workup for an adult with isolated total bilirubin elevation and otherwise normal CBC (complete blood count) and CMP (comprehensive metabolic panel)?
How is leptospirosis severity classified into mild, moderate, and severe forms?
Can I take phenobarbital with amoxicillin, paracetamol, and ambroxol?
Does PT refer to SGPT (alanine aminotransferase) rather than prothrombin time?
What CPT billing code should be used for a routine annual preventive physical exam for an 82‑year‑old female patient who is not undergoing the Medicare Annual Wellness Visit?
What do the various colors of a nephrostomy drainage bag represent?
What does a colored ring on a nephrostomy tube indicate and how should it be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.